PubMed for id: 255877

Year	Number of Results
1991	1
1992	1
1998	1
2000	1
2002	2
2003	2
2004	2
2009	1
2011	2
2012	2
2013	1
2014	3
2015	3
2017	3
2018	2
2019	1
2020	2
2021	3
2022	2
2023	2
2024	0

1

BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation.

Li X, Guo M, Yang L, Cheng Z, Yu X, Han Z, Liu F, Sun Q, Han X, Yu J, Liang P. Li X, et al. J Cancer Res Ther. 2021 Jul;17(3):644-651. doi: 10.4103/jcrt.JCRT_1504_20. J Cancer Res Ther. 2021. PMID: 34269294 Free article.

2

Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.

Xiang T, Tang J, Li L, Peng W, Du Z, Wang X, Li Q, Xu H, Xiong L, Xu C, Le X, Wei X, Yu F, Li S, Xiao Q, Luo B, Xiang X, Huang A, Lin Y, Ren G, Tao Q. Xiang T, et al. Theranostics. 2019 Oct 18;9(26):8182-8195. doi: 10.7150/thno.34983. eCollection 2019. Theranostics. 2019. PMID: 31754389 Free PMC article.

3

BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.

Gu Y, Li A, Sun H, Li X, Zha H, Zhao J, Xie J, Zeng Z, Zhou L. Gu Y, et al. Int J Mol Med. 2018 May;41(5):2660-2668. doi: 10.3892/ijmm.2018.3451. Epub 2018 Feb 1. Int J Mol Med. 2018. PMID: 29393377 Free PMC article.

4

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.

Wang W, Huang P, Wu P, Kong R, Xu J, Zhang L, Yang Q, Xie Q, Zhang L, Zhou X, Chen L, Xie H, Zhou L, Zheng S. Wang W, et al. Oncotarget. 2015 Aug 21;6(24):20252-65. doi: 10.18632/oncotarget.3857. Oncotarget. 2015. PMID: 25970780 Free PMC article.

5

B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.

Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J. Wang J, et al. Cancer Lett. 2014 Dec 28;355(2):192-200. doi: 10.1016/j.canlet.2014.08.025. Epub 2014 Sep 11. Cancer Lett. 2014. PMID: 25218345 Free article.

6

The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.

Deng J, Liang H, Dong Q, Hou Y, Xie X, Yu J, Fan D, Hao X. Deng J, et al. Open Biol. 2014 Jul;4(7):140067. doi: 10.1098/rsob.140067. Open Biol. 2014. PMID: 25008234 Free PMC article.

7

Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.

Yang Q, Gao J, Xu L, Zeng Z, Sung JJ, Yu J. Yang Q, et al. Biomarkers. 2013 Dec;18(8):721-5. doi: 10.3109/1354750X.2013.853839. Epub 2013 Nov 6. Biomarkers. 2013. PMID: 24191714

8

Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.

Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, Jin H, Zeng Z, Sung JJ, Yu J. Xu L, et al. Gut. 2012 Jul;61(7):977-85. doi: 10.1136/gutjnl-2011-300411. Epub 2011 Sep 13. Gut. 2012. PMID: 21917650

9

Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization.

Fitzgibbon J, Neat MJ, Jones L, Foot N, Lister TA, Gupta RK. Fitzgibbon J, et al. Cytogenet Cell Genet. 2000;89(3-4):218-9. doi: 10.1159/000015617. Cytogenet Cell Genet. 2000. PMID: 10965127 No abstract available.

10

BCL6B Contributes to Ocular Vascular Diseases via Notch Signal Silencing.

Tanaka M, Nakamura S, Sakaue T, Yamamoto T, Maekawa M, Nishinaka A, Yasuda H, Yunoki K, Sato Y, Sawa M, Yoshino K, Shimazawa M, Hatano M, Tokuhisa T, Higashiyama S, Hara H. Tanaka M, et al. Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):927-942. doi: 10.1161/ATVBAHA.123.318987. Epub 2023 Apr 20. Arterioscler Thromb Vasc Biol. 2023. PMID: 37078291 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year